Extraction review
1 candidate(s) · status completed · 2026-06-14 20:33
Review before activation. Approving creates a structured, source-attributed record (asset, dosing reference, or evidence claim). Rejected candidates are discarded. Unreviewed candidates never reach the Copilot or protocol builder.
Candidate assets
1
- LL-37conf 90%pending
LL-37 is the only human cathelicidin-derived antimicrobial peptide and a central effector of innate immunity.